Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1990 Oct;30(4):613–615. doi: 10.1111/j.1365-2125.1990.tb03821.x

Tremor and the anti-obesity drug BRL 26830A.

A A Connacher 1, M Lakie 1, N Powers 1, R A Elton 1, E G Walsh 1, R T Jung 1
PMCID: PMC1368253  PMID: 1981320

Abstract

The thermogenic beta 3-adrenoceptor agonist BRL 26830A has been shown to increase weight loss in dieting subjects but tremor was a frequent adverse effect. We have investigated the magnitude and nature of this tremor after a single oral dose in 18 subjects. Two complementary techniques were used to attach the recording apparatus to the subjects to give both isotonic and isometric measures of tremor. Increases of 84% and 40% respectively were found due to exaggeration of physiological tremor presumably mediated through concomitant beta 2-adrenoceptor stimulation. The use of beta 3-adrenoceptor agonist drugs in the treatment of obesity may increase but the development of an agent without tremor inducing properties would be an obvious advantage.

Full text

PDF
615

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arch J. R., Ainsworth A. T., Cawthorne M. A., Piercy V., Sennitt M. V., Thody V. E., Wilson C., Wilson S. Atypical beta-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature. 1984 May 10;309(5964):163–165. doi: 10.1038/309163a0. [DOI] [PubMed] [Google Scholar]
  2. Chapman B. J., Farquahar D. L., Galloway S. M., Simpson G. K., Munro J. F. The effects of a new beta-adrenoceptor agonist BRL 26830A in refractory obesity. Int J Obes. 1988;12(2):119–123. [PubMed] [Google Scholar]
  3. Connacher A. A., Jung R. T., Mitchell P. E. Weight loss in obese subjects on a restricted diet given BRL 26830A, a new atypical beta adrenoceptor agonist. Br Med J (Clin Res Ed) 1988 Apr 30;296(6631):1217–1220. doi: 10.1136/bmj.296.6631.1217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Emorine L. J., Marullo S., Briend-Sutren M. M., Patey G., Tate K., Delavier-Klutchko C., Strosberg A. D. Molecular characterization of the human beta 3-adrenergic receptor. Science. 1989 Sep 8;245(4922):1118–1121. doi: 10.1126/science.2570461. [DOI] [PubMed] [Google Scholar]
  5. Lakie M., Walsh E. G., Wright G. W. Resonance at the wrist demonstrated by the use of a torque motor: an instrumental analysis of muscle tone in man. J Physiol. 1984 Aug;353:265–285. doi: 10.1113/jphysiol.1984.sp015335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Marsden C. D., Foley T. H., Owen D. A., McAllister R. G. Peripheral beta-adrenergic receptors concerned with tremor. Clin Sci. 1967 Aug;33(1):53–65. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES